These results suggest that in normal breast epithelial cells or breast cancer cells of low malignancy, overexpression of DANCR is capable of down‐regulating SOCS3 via interaction with EZH2, which is consistent with that of malignant cell lines. The gene discussed is EZH2; the disease is breast cancer.